Physician profile
Tracey Shears-Bethke
NPI 1073549333
$296.95
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.02 · 2020: $71.71 · 2021: $129 · 2022: $29.61.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $106.50 | 2020-2021 | |
| Abbvie INC. | $51.90 | 2021-2022 | |
| Amgen INC. | $29.77 | 2020 | |
| Novo Nordisk INC | $29.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.27 | 2019 | |
| Eisai INC. | $15.77 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.76 | 2022 | |
| Ucb, INC. | $12.23 | 2021 | |
| Sanofi Pasteur INC. | $11.44 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Shears-Bethke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.